NO971015D0 - Forbindelser og metoder for behandling av cancer - Google Patents

Forbindelser og metoder for behandling av cancer

Info

Publication number
NO971015D0
NO971015D0 NO971015A NO971015A NO971015D0 NO 971015 D0 NO971015 D0 NO 971015D0 NO 971015 A NO971015 A NO 971015A NO 971015 A NO971015 A NO 971015A NO 971015 D0 NO971015 D0 NO 971015D0
Authority
NO
Norway
Prior art keywords
cancer
compounds
treatment
methods
Prior art date
Application number
NO971015A
Other languages
English (en)
Other versions
NO971015L (no
NO313268B1 (no
Inventor
Chung K Chu
Yung-Chi Cheng
Original Assignee
Univ Georgia
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/301,298 external-priority patent/US5817667A/en
Application filed by Univ Georgia, Univ Yale filed Critical Univ Georgia
Publication of NO971015D0 publication Critical patent/NO971015D0/no
Publication of NO971015L publication Critical patent/NO971015L/no
Publication of NO313268B1 publication Critical patent/NO313268B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
NO19971015A 1994-09-06 1997-03-05 Anvendelse av (2S,4S)-1-(2-hydroksymetyl-1,3-dioksolan-4- yl)cytosin for fremstilling av medikamenter for behandling avcancer NO313268B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/301,298 US5817667A (en) 1991-04-17 1994-09-06 Compounds and methods for the treatment of cancer
US39063395A 1995-02-17 1995-02-17
PCT/US1995/011464 WO1996007413A1 (en) 1994-09-06 1995-09-05 Compounds and methods for the treatment of cancer

Publications (3)

Publication Number Publication Date
NO971015D0 true NO971015D0 (no) 1997-03-05
NO971015L NO971015L (no) 1997-03-05
NO313268B1 NO313268B1 (no) 2002-09-09

Family

ID=26972285

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19971015A NO313268B1 (no) 1994-09-06 1997-03-05 Anvendelse av (2S,4S)-1-(2-hydroksymetyl-1,3-dioksolan-4- yl)cytosin for fremstilling av medikamenter for behandling avcancer

Country Status (31)

Country Link
US (3) US6063787A (no)
EP (2) EP0781136B1 (no)
JP (1) JP3979662B2 (no)
KR (1) KR100374477B1 (no)
CN (3) CN1111409C (no)
AP (1) AP783A (no)
AT (1) ATE267015T1 (no)
AU (1) AU704977B2 (no)
BG (1) BG63122B1 (no)
BR (1) BR9508886A (no)
CA (1) CA2199117C (no)
CZ (1) CZ297873B6 (no)
DE (1) DE69533066T2 (no)
DK (1) DK0781136T3 (no)
ES (1) ES2219666T3 (no)
FI (1) FI970918A (no)
HU (1) HUT77172A (no)
IL (1) IL115156A (no)
IS (1) IS2011B (no)
MY (1) MY121548A (no)
NO (1) NO313268B1 (no)
NZ (1) NZ335013A (no)
OA (1) OA10473A (no)
PL (2) PL189288B1 (no)
PT (1) PT781136E (no)
RO (1) RO118748B1 (no)
RU (1) RU2168995C2 (no)
SI (1) SI0781136T1 (no)
SK (1) SK284564B6 (no)
WO (1) WO1996007413A1 (no)
ZA (1) ZA957483B (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6903224B2 (en) 1988-04-11 2005-06-07 Biochem Pharma Inc. Substituted 1,3-oxathiolanes
US5827727A (en) * 1990-02-01 1998-10-27 Emory University Method of resolution of 1,3-oxathiolane nucleoside enantiomers
IL115156A (en) * 1994-09-06 2000-07-16 Univ Georgia Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines
US6022876A (en) * 1996-11-15 2000-02-08 Yale University L-β-dioxolane uridine analogs and methods for treating and preventing Epstein-Barr virus infections
AU9016998A (en) 1997-08-08 1999-03-01 Newbiotics, Inc. Methods and compositions for overcoming resistance to biologic and chemotherapy
CN1192102C (zh) 1998-01-23 2005-03-09 新生物生物公司 酶催化的治疗剂
US7462605B2 (en) 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
EP1058686B1 (en) 1998-02-25 2006-11-02 Emory University 2'-fluoronucleosides
AU2004201676B2 (en) * 1999-03-29 2006-03-09 University Of Georgia Research Foundation, Inc. Methods of treating leukemia
ES2333399T3 (es) * 1999-03-29 2010-02-22 Shire Canada Inc. Metodos para tratar una leucemia.
US6653318B1 (en) 1999-07-21 2003-11-25 Yale University 5-(E)-Bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use
US6683061B1 (en) 1999-07-22 2004-01-27 Newbiotics, Inc. Enzyme catalyzed therapeutic activation
WO2001022950A2 (en) 1999-09-24 2001-04-05 Shire Biochem Inc. Diosolane nucleoside analogs for the treatment or prevention of viral infection
US6566365B1 (en) 1999-11-04 2003-05-20 Biochem Pharma Inc. Method for the treatment of Flaviviridea viral infection using nucleoside analogues
EP1634888A3 (en) 1999-11-12 2007-11-21 Pharmasset, Inc. Synthesis of 2'-deoxy-L-nucleosides
US20030013660A1 (en) * 2000-10-13 2003-01-16 Shire Biochem Inc. Dioxolane analogs for improved inter-cellular delivery
US7138388B2 (en) 2001-01-19 2006-11-21 Celmed Oncology (Usa), Inc. Methods to treat autoimmune and inflammatory conditions
CN1744902B (zh) * 2001-03-23 2010-05-26 希拉加拿大股份有限公司 治疗癌症的药物组合
WO2002076472A2 (en) 2001-03-23 2002-10-03 Shire Biochem Inc. Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs
WO2002078678A2 (en) * 2001-03-30 2002-10-10 Shire Biochem Inc. Methods of treating cancer using cyplastin combined with a dioxolane nucleoside such as troxacitabine
AU2002336864B2 (en) * 2001-11-02 2006-08-17 Shire Biochem Inc. Pharmaceutical compositions for the treatment of leukemia comprising dioxolane nucleosides analogs
MXPA04004532A (es) * 2001-11-19 2004-08-11 Medigene Ag Medicamento para el tratamiento de enfermedades tumorales y virales de la piel.
JP4299779B2 (ja) 2002-06-21 2009-07-22 エルジー エレクトロニクス インコーポレーテッド ビデオデータの再生を管理するためのデータ構造を有する記録媒体
MXPA04002365A (es) 2002-06-21 2004-11-22 Lg Electronics Inc Medio de grabacion que tiene estructura de datos para manejar la reproduccion de datos de video grabados en el mismo.
KR20040000290A (ko) 2002-06-24 2004-01-03 엘지전자 주식회사 고밀도 광디스크의 멀티 경로 데이터 스트림 관리방법
WO2004001752A1 (en) 2002-06-24 2003-12-31 Lg Electronics Inc. Recording medium having data structure for managing reproduction of multiple title video data recorded thereon and recording and reproducing methods and apparatuses
JP4312151B2 (ja) 2002-06-28 2009-08-12 エルジー エレクトロニクス インコーポレーテッド 多重経路データの記録及び再生を管理するためのデータ構造を有する記録媒体と、それによって記録し、再生する方法及び装置
RU2347284C2 (ru) 2002-10-14 2009-02-20 Эл Джи Электроникс Инк. Носитель записи со структурой данных для управления воспроизведением записанного на нем множества аудиопотоков и способы и устройства записи и воспроизведения
JP4903998B2 (ja) 2002-10-15 2012-03-28 エルジー エレクトロニクス インコーポレイティド 記録された複数のグラフィックストリームの再生を管理するためのデータ構造を有する記録媒体、それによる記録及び再生方法及び装置
US7720356B2 (en) 2002-11-12 2010-05-18 Lg Electronics Inc Recording medium having data structure for managing reproduction of multiple reproduction path video data recorded thereon and recording and reproducing methods and apparatuses
US7664372B2 (en) 2002-11-20 2010-02-16 Lg Electronics Inc. Recording medium having data structure for managing reproduction of multiple component data recorded thereon and recording and reproducing methods and apparatuses
US7693394B2 (en) 2003-02-26 2010-04-06 Lg Electronics Inc. Recording medium having data structure for managing reproduction of data streams recorded thereon and recording and reproducing methods and apparatuses
US7809775B2 (en) 2003-02-27 2010-10-05 Lg Electronics, Inc. Recording medium having data structure for managing playback control recorded thereon and recording and reproducing methods and apparatuses
CN100397882C (zh) 2003-02-28 2008-06-25 Lg电子株式会社 具有用于管理记录其上的视频数据的随机/洗牌重现的数据结构的记录媒体以及记录和重现的方法和装置
US7620301B2 (en) 2003-04-04 2009-11-17 Lg Electronics Inc. System and method for resuming playback
US7910138B2 (en) 2003-10-09 2011-03-22 Medigene Ag Use of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin
EP1890537B1 (en) 2005-06-07 2012-08-08 Yale University Methods of treating cancer and other conditions or disease states using lfmau and ldt
CN101511375B (zh) * 2005-12-02 2012-09-05 耶鲁大学 L-胞嘧啶核苷类似物在制备用于治疗癌症和其它病症或疾病状态的药物中的应用
NO324263B1 (no) * 2005-12-08 2007-09-17 Clavis Pharma Asa Kjemiske forbindelser, anvendelse derav ved behandling av kreft, samt farmasoytiske preparater som omfatter slike forbindelser
KR20090057050A (ko) * 2006-09-01 2009-06-03 유니버시티 오브 조지아 리서치 파운데이션, 인코포레이티드 암치료를 위한 트록사시타빈 전구약물
CN103720693A (zh) * 2011-11-15 2014-04-16 张始状 人体五种正常碱基在制备治疗肿瘤药物中的应用
CN102406649A (zh) * 2011-11-15 2012-04-11 张始状 人体五种正常碱基在制备治疗肿瘤药物中的应用
SG10201609131YA (en) 2016-11-01 2018-06-28 Xylonix Ip Holdings Pte Ltd Zinc-pga compositions and methods for treating cancer
JP7110203B2 (ja) * 2016-12-28 2022-08-01 トランジェーヌ 腫瘍溶解性ウイルスおよび治療用分子
SG10201708886RA (en) * 2017-10-30 2019-05-30 Xylonix Ip Holdings Pte Ltd α-PGA-ZINC COMPOSITIONS AND METHODS FOR TREATING CANCER

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000137A (en) * 1975-06-10 1976-12-28 American Home Products Corporation Antitumor derivatives of periodate-oxidized nucleosides
JPS5668674A (en) * 1979-11-08 1981-06-09 Shionogi & Co Ltd 5-fluorouracil derivative
HU196607B (en) * 1985-05-15 1988-12-28 Wellcome Found Process for producing dideoxy-nucleosides and pharmaceutics comprising such compounds
JPS62501712A (ja) * 1985-08-26 1987-07-09 アメリカ合衆国 ２′、３′―ジデオキシイノシン、２′，３′―ジデオキシグアノシンまたは２′，３′―ジデオキシアデノシンを含有する抗ｈｔｌｖ―３／ｌａｖ剤
US4879277A (en) * 1985-08-26 1989-11-07 The United States Of America As Represented By The Department Of Health And Human Services Antiviral compositions and methods
ATE190064T1 (de) * 1985-09-17 2000-03-15 Wellcome Found Kombination therapeutische nukleoside mit weiteren therapeutisch wirksamen komponenten.
IN164556B (no) * 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
US4916122A (en) * 1987-01-28 1990-04-10 University Of Georgia Research Foundation, Inc. 3'-Azido-2',3'-dideoxyuridine anti-retroviral composition
FR2601385B1 (fr) * 1986-07-09 1989-09-29 Sucre Rech & Dev Procede de preparation a partir de saccharose d'un melange de sucres a haute teneur en isomaltose par voie enzymatique et produits obtenus
US4963533A (en) * 1986-10-24 1990-10-16 Stichting Rega Vzw (Rega) Therapeutic application of dideoxycytidinene
US5215971A (en) * 1986-12-19 1993-06-01 Medivir Ab Antiviral pharmaceutical composition comprising 5-substituted pyrimidine nucleosides
AU613026B2 (en) * 1987-03-24 1991-07-25 Nycomed As 2',3' dideoxyribofuranoxide derivatives
US5185437A (en) * 1987-04-09 1993-02-09 Burroughs Wellcome Co. Therapeutic nucleosides
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5466806A (en) * 1989-02-08 1995-11-14 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
NZ228645A (en) * 1988-04-11 1991-09-25 Iaf Biochem Int 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections
US5270315A (en) * 1988-04-11 1993-12-14 Biochem Pharma Inc. 4-(purinyl bases)-substituted-1,3-dioxlanes
US5041449A (en) * 1988-04-11 1991-08-20 Iaf Biochem International, Inc. 4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections
US4900828A (en) * 1988-05-12 1990-02-13 Hoffmann-Laroche Inc. Intermediate compounds and an improved procedure for the synthesis of 2',3'-dideoxycytidine
SE8802687D0 (sv) * 1988-07-20 1988-07-20 Astra Ab Nucleoside derivatives
JP2788084B2 (ja) * 1988-12-19 1998-08-20 ザ ウエルカム フアウンデーシヨン リミテツド 抗ウイルス化合物
UA45942A (uk) * 1989-02-08 2002-05-15 Біокем Фарма, Інк. 1,3-оксатіолан, його похідні, спосіб (варіанти) його одержання та фармацевтична композиція
NZ233197A (en) * 1989-04-13 1991-11-26 Richard Thomas Walker Aromatically substituted nucleotide derivatives, intermediates therefor and pharmaceutical compositions
US5059690A (en) * 1990-03-01 1991-10-22 E. R. Squibb & Sons, Inc. Purinyl tetrahydrofurans
US5071983A (en) * 1989-10-06 1991-12-10 Burroughs Wellcome Co. Therapeutic nucleosides
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
IE904378A1 (en) * 1989-12-20 1991-07-03 Abbott Lab Analogs of oxetanyl purines and pyrimidines
US5700937A (en) * 1990-02-01 1997-12-23 Emory University Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
US5276151A (en) * 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
US5527782A (en) * 1990-03-13 1996-06-18 Acic (Canada) Inc. 5-halo-2,3'-O-cyclocytidines
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
US5179104A (en) * 1990-12-05 1993-01-12 University Of Georgia Research Foundation, Inc. Process for the preparation of enantiomerically pure β-D-(-)-dioxolane-nucleosides
WO1992010496A1 (en) * 1990-12-05 1992-06-25 University Of Georgia Research Foundation, Inc. ENANTIOMERICALLY PURE β-L-(-)-1,3-OXATHIOLANE NUCLEOSIDES
US5444063A (en) * 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
US5248776A (en) * 1990-12-05 1993-09-28 University Of Georgia Research Foundation, Inc. Process for enantiomerically pure β-L-1,3-oxathiolane nucleosides
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
IL100965A (en) * 1991-02-22 1999-12-31 Univ Emory 2 - Hydroxymethyl - 5 -) 5 - Fluorocytocin - 1 - Eyal (- 1, 3 - Oxathiolane, its resolution and pharmaceuticals containing it
DE69233693T2 (de) * 1991-03-06 2008-01-24 Emory University Salze und Amide von (-) cis 5-Fluoro-2'-deoxy-3'-thiacytidine geeignet für die Behandlung von Hepatitis B
GB9104740D0 (en) * 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
US5817667A (en) * 1991-04-17 1998-10-06 University Of Georgia Research Foudation Compounds and methods for the treatment of cancer
WO1992018517A1 (en) * 1991-04-17 1992-10-29 Yale University Method of treating or preventing hepatitis b virus
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923640B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9111902D0 (en) * 1991-06-03 1991-07-24 Glaxo Group Ltd Chemical compounds
GB9116601D0 (en) * 1991-08-01 1991-09-18 Iaf Biochem Int 1,3-oxathiolane nucleoside analogues
GB9226927D0 (en) 1992-12-24 1993-02-17 Iaf Biochem Int Dideoxy nucleoside analogues
US5627160A (en) * 1993-05-25 1997-05-06 Yale University L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents
WO1995018137A1 (en) * 1993-12-30 1995-07-06 Genta Incorporated Improved process for the purification of oligomers
US5587362A (en) * 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
IL115156A (en) * 1994-09-06 2000-07-16 Univ Georgia Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines
US5971983A (en) * 1997-05-09 1999-10-26 The Regents Of The University Of California Tissue ablation device and method of use

Also Published As

Publication number Publication date
CA2199117A1 (en) 1996-03-14
EP0781136B1 (en) 2004-05-19
SK28197A3 (en) 1997-09-10
US7262213B2 (en) 2007-08-28
CZ63397A3 (en) 1997-07-16
WO1996007413A1 (en) 1996-03-14
OA10473A (en) 2002-04-08
DE69533066D1 (de) 2004-06-24
SI0781136T1 (en) 2004-08-31
FI970918A0 (fi) 1997-03-04
PL188359B1 (pl) 2005-01-31
CN1111409C (zh) 2003-06-18
HUT77172A (hu) 1998-03-02
US8076347B2 (en) 2011-12-13
AU704977B2 (en) 1999-05-13
CN1251680C (zh) 2006-04-19
NO971015L (no) 1997-03-05
IL115156A (en) 2000-07-16
AP9700939A0 (en) 1997-04-30
RO118748B1 (ro) 2003-10-30
BG101284A (en) 1998-03-31
ES2219666T3 (es) 2004-12-01
EP0781136A4 (en) 1999-06-23
KR970705393A (ko) 1997-10-09
ZA957483B (en) 1997-06-06
NZ335013A (en) 2000-07-28
AP783A (en) 1999-11-17
IS2011B (is) 2005-05-13
EP0781136A1 (en) 1997-07-02
CN1160351A (zh) 1997-09-24
ATE267015T1 (de) 2004-06-15
DE69533066T2 (de) 2005-06-02
BR9508886A (pt) 1997-12-30
MY121548A (en) 2006-02-28
US6063787A (en) 2000-05-16
FI970918A (fi) 1997-05-02
RU2168995C2 (ru) 2001-06-20
PT781136E (pt) 2004-09-30
AU3586295A (en) 1996-03-27
NO313268B1 (no) 2002-09-09
CN1448142A (zh) 2003-10-15
CZ297873B6 (cs) 2007-04-18
PL189288B1 (pl) 2005-07-29
IL115156A0 (en) 1995-12-31
BG63122B1 (en) 2001-04-30
IS4434A (is) 1997-03-04
SK284564B6 (sk) 2005-06-02
US20050261320A1 (en) 2005-11-24
DK0781136T3 (da) 2004-08-02
CA2199117C (en) 2006-04-11
US20080171758A1 (en) 2008-07-17
JP3979662B2 (ja) 2007-09-19
JPH10506385A (ja) 1998-06-23
CN1827108A (zh) 2006-09-06
KR100374477B1 (ko) 2003-06-19
EP1468687A1 (en) 2004-10-20
PL318971A1 (en) 1997-07-21

Similar Documents

Publication Publication Date Title
NO971015D0 (no) Forbindelser og metoder for behandling av cancer
NO991381D0 (no) Kombinasjonsterapi for behandling av psykoser
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
NO994069D0 (no) Forbindelser for immunoterapi av prostatacancer og fremgangsmåte for anvendelse derav
NO991955D0 (no) FremgangsmÕte for behandling av hydrokarboner
BR9603841A (pt) Aparelho para o tratamento hipertérmico de tumores
FI964874A (fi) Vihannesten käsittely
NO994778D0 (no) FremgangsmÕter og sammensetninger for behandling av tarmbetennelse
FI971568A (fi) Menetelmä resistenttien kasvainten hoitamiseksi
NO991192L (no) Middel for behandling av prostatahypertrofi og prostatakreft
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
NO953254D0 (no) Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter
NO20054619D0 (no) Sammensetninger og fremgangsmater for behandling av underjordiske formasjoner
IL114119A0 (en) Compositions and methods for the treatment of tumors
NO983512D0 (no) Midler for behandling og forhindring av AIDS
NO931445L (no) Overflatebehandling og fremgangsmaate for tilvirkning av disse
NO961226D0 (no) Blandinger for forebyggelse og behandling av viralinduserte tumorer
NO994631D0 (no) Fremgangsmaater og sammensetninger for behandling av eggstokkreft
IL115320A0 (en) Retinoyloxy (substituted) methyl butyrates useful for the treatment of cancer and other proliferative diseases
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
NO981822L (no) Anvendelse av proteinet GAX for behandling av cancer
NO982582D0 (no) FremgangsmÕte for behandling av smerte
GB9010058D0 (en) Method and composition for the treatment of cancer
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser
NO985068L (no) Vaksiner for behandling av lymfom og leukemi

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees